Exact Mass: 253.0515

Exact Mass Matches: 253.0515

Found 32 metabolites which its exact mass value is equals to given mass value 253.0515, within given mass tolerance error 0.001 dalton. Try search metabolite list with more accurate mass tolerance error 0.0002 dalton.

Sulfamethoxazole

4-amino-N-(5-methyl-1,2-oxazol-3-yl)benzene-1-sulfonamide

C10H11N3O3S (253.0521)


Sulfamethoxazole is only found in individuals that have used or taken this drug. It is a bacteriostatic antibacterial agent that interferes with folic acid synthesis in susceptible bacteria. Its broad spectrum of activity has been limited by the development of resistance. (From Martindale, The Extra Pharmacopoeia, 30th ed, p208)Sulfonamides inhibit the enzymatic conversion of pteridine and p-aminobenzoic acid (PABA) to dihydropteroic acid by competing with PABA for binding to dihydrofolate synthetase, an intermediate of tetrahydrofolic acid (THF) synthesis. THF is required for the synthesis of purines and dTMP and inhibition of its synthesis inhibits bacterial growth. Pyrimethamine and trimethoprim inhibit dihydrofolate reductase, another step in THF synthesis, and therefore act synergistically with the sulfonamides. J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01E - Sulfonamides and trimethoprim > J01EC - Intermediate-acting sulfonamides COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C254 - Anti-Infective Agent > C29739 - Sulfonamide Anti-Infective Agent D000890 - Anti-Infective Agents > D013424 - Sulfanilamides CONFIDENCE standard compound; EAWAG_UCHEM_ID 298 CONFIDENCE standard compound; INTERNAL_ID 1018 Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

4-[2-(4-chlorophenyl)ethylamino]-4-oxobut-2-enoic acid

4-[2-(4-chlorophenyl)ethylamino]-4-oxobut-2-enoic acid

C12H12ClNO3 (253.0506)


   

sulfamethoxazole

sulfamethoxazole

C10H11N3O3S (253.0521)


J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01E - Sulfonamides and trimethoprim > J01EC - Intermediate-acting sulfonamides An isoxazole (1,2-oxazole) compound having a methyl substituent at the 5-position and a 4-aminobenzenesulfonamido group at the 3-position. COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C254 - Anti-Infective Agent > C29739 - Sulfonamide Anti-Infective Agent D000890 - Anti-Infective Agents > D013424 - Sulfanilamides Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS CONFIDENCE Reference Standard (Level 1); HBM4EU - science and policy for a healthy future (https://www.hbm4eu.eu); Flow Injection CONFIDENCE Reference Standard (Level 1); HBM4EU - science and policy for a healthy future (https://www.hbm4eu.eu) CONFIDENCE standard compound; INTERNAL_ID 2343 CONFIDENCE standard compound; INTERNAL_ID 8563 CONFIDENCE Reference Standard (Level 1) CONFIDENCE standard compound; INTERNAL_ID 1018

   

Sulfamethoxazole; AIF; CE0; CorrDec

Sulfamethoxazole; AIF; CE0; CorrDec

C10H11N3O3S (253.0521)


   

Sulfamethoxazole; AIF; CE10; CorrDec

Sulfamethoxazole; AIF; CE10; CorrDec

C10H11N3O3S (253.0521)


   

Sulfamethoxazole; AIF; CE30; CorrDec

Sulfamethoxazole; AIF; CE30; CorrDec

C10H11N3O3S (253.0521)


   

Sulfamethoxazole; AIF; CE0; MS2Dec

Sulfamethoxazole; AIF; CE0; MS2Dec

C10H11N3O3S (253.0521)


   

Sulfamethoxazole; AIF; CE10; MS2Dec

Sulfamethoxazole; AIF; CE10; MS2Dec

C10H11N3O3S (253.0521)


   

Sulfamethoxazole; AIF; CE30; MS2Dec

Sulfamethoxazole; AIF; CE30; MS2Dec

C10H11N3O3S (253.0521)


   

Sulfamethoxazole; LC-tDDA; CE10

Sulfamethoxazole; LC-tDDA; CE10

C10H11N3O3S (253.0521)


   

Sulfamethoxazole; LC-tDDA; CE20

Sulfamethoxazole; LC-tDDA; CE20

C10H11N3O3S (253.0521)


   

Sulfamethoxazole; LC-tDDA; CE30

Sulfamethoxazole; LC-tDDA; CE30

C10H11N3O3S (253.0521)


   

Sulfamethoxazole; LC-tDDA; CE40

Sulfamethoxazole; LC-tDDA; CE40

C10H11N3O3S (253.0521)


   

3-METHYL-1-(4-SULFOAMIDOPHENYL)-5-PYRA&

3-METHYL-1-(4-SULFOAMIDOPHENYL)-5-PYRA&

C10H11N3O3S (253.0521)


   

SulfaMethoxazole-13C6

SulfaMethoxazole-13C6

C10H11N3O3S (253.0521)


   

1-(2-CHLORO-ACETYL)-3-METHYL-UREA

1-(2-CHLORO-ACETYL)-3-METHYL-UREA

C12H12ClNO3 (253.0506)


   

3-Fluoro-N-(3,4,5-trifluorobenzylidene)aniline

3-Fluoro-N-(3,4,5-trifluorobenzylidene)aniline

C13H7F4N (253.0515)


   

(R)-4-BENZYL-3-(2-CHLOROACETYL)OXAZOLIDIN-2-ONE

(R)-4-BENZYL-3-(2-CHLOROACETYL)OXAZOLIDIN-2-ONE

C12H12ClNO3 (253.0506)


   

(n-chloroacetyl)-(4s)-benzyl-2-oxazolidinone

(n-chloroacetyl)-(4s)-benzyl-2-oxazolidinone

C12H12ClNO3 (253.0506)


   

3-Methyl-1-(3-sulfoamidophenyl)-5-pyrazolone

3-Methyl-1-(3-sulfoamidophenyl)-5-pyrazolone

C10H11N3O3S (253.0521)


   

2-[2-(2-CHLOROETHOXY)ETHYL]-1H-ISOINDOLE-1,3(2H)-DIONE

2-[2-(2-CHLOROETHOXY)ETHYL]-1H-ISOINDOLE-1,3(2H)-DIONE

C12H12ClNO3 (253.0506)


   

3-Pyrrolidinecarboxylic acid, 1-[(4-chlorophenyl)methyl]-5-oxo-

3-Pyrrolidinecarboxylic acid, 1-[(4-chlorophenyl)methyl]-5-oxo-

C12H12ClNO3 (253.0506)


   

2-(4-chlorophenyl)-1-methyl-5-oxopyrrolidine-3-carboxylic acid

2-(4-chlorophenyl)-1-methyl-5-oxopyrrolidine-3-carboxylic acid

C12H12ClNO3 (253.0506)


   

1-(2-CHLOROBENZOYL)PYRROLIDINE-2-CARBOXYLICACID

1-(2-CHLOROBENZOYL)PYRROLIDINE-2-CARBOXYLICACID

C12H12ClNO3 (253.0506)


   

1-ISOPROPYL-7-(METHYLTHIO)-1H-PYRIMIDO[4,5-D][1,3]OXAZINE-2,4-DIONE

1-ISOPROPYL-7-(METHYLTHIO)-1H-PYRIMIDO[4,5-D][1,3]OXAZINE-2,4-DIONE

C10H11N3O3S (253.0521)


   

7-(METHYLTHIO)-1-PROPYL-1H-PYRIMIDO[4,5-D][1,3]OXAZINE-2,4-DIONE

7-(METHYLTHIO)-1-PROPYL-1H-PYRIMIDO[4,5-D][1,3]OXAZINE-2,4-DIONE

C10H11N3O3S (253.0521)


   

aminomalononitrile p-toluenesulfonate

aminomalononitrile p-toluenesulfonate

C10H11N3O3S (253.0521)


   

1-(4-chlorobenzoyl)pyrrolidine-2-carboxylic acid

1-(4-chlorobenzoyl)pyrrolidine-2-carboxylic acid

C12H12ClNO3 (253.0506)


   

N-[(2-Methyl-5-nitrophenyl)carbamothioyl]acetamide

N-[(2-Methyl-5-nitrophenyl)carbamothioyl]acetamide

C10H11N3O3S (253.0521)


   

m-(4,5-dihydro-5-imino-3-methyl-1H-pyrazol-1-yl)benzenesulphonic acid

m-(4,5-dihydro-5-imino-3-methyl-1H-pyrazol-1-yl)benzenesulphonic acid

C10H11N3O3S (253.0521)


   

4-Amino-N-(4-methyl-1,2-oxazol-3-yl)benzene-1-sulfonamide

4-Amino-N-(4-methyl-1,2-oxazol-3-yl)benzene-1-sulfonamide

C10H11N3O3S (253.0521)


   

1-Methyl-3-phenyl-1H-pyrazol-5-ylsulfamic acid

1-Methyl-3-phenyl-1H-pyrazol-5-ylsulfamic acid

C10H11N3O3S (253.0521)